The use of essential drugs: Eight report of the WHO Expert Committee (WHO, 1998, 84 p.): WHO Expert Committee on the Use of Essential Drugs

The use of essential drugs: Eight report of the WHO Expert Committee (WHO, 1998, 84 p.)

		(introductory text...)
		WHO Expert Committee on the Use of Essential Drugs - Geneva, 1-5 December 1997
		1. Introduction
		2. Guidelines for establishing a national programme for essential drugs
		3. Criteria for the selection of essential drugs
		4. Guidelines for the selection of pharmaceutical dosage forms
		5. Quality assurance
		6. Reserve anti-infective agents and monitoring of resistance
		7. Applications of the essential drugs concept
		8. Essential drugs and primary health care
		9. Drug donations
		10. Post-registration drug studies
		11. Research and development
		12. Nomenclature
		13. Drug information and educational activities
		14. Selection and updating of lists of essential drugs
		15. Model List of Essential Drugs (tenth list)
		16. Considerations and changes made in revising the model list
		17. Glossary of terms used in the report
		Acknowledgement
		References
		Annex 1. Application form for inclusion in the Model List of Essential Drugs1
		Selected WHO publications of related interest
		Back Cover

WHO Expert Committee on the Use of Essential Drugs - Geneva, 1-5 December 1997

Members

Professor P.M. de Buschiazzo, Department of Pharmacology, School of Medicine, University of La Plata, La Plata, Argentina (Vice-Chairman)

Professor H. Fraser, Professor of Medicine and Clinical Pharmacology, Faculty of Medical Sciences, Queen Elizabeth Hospital, University of the West Indies, Bridgetown, Barbados (Rapporteur)

Dr A. Haeri, Dean, School of Medicine, Shaheed Beheshti University of Medical Sciences, Eveen, Teheran, Islamic Republic of Iran

Professor M. Hassar, Director, Department of Pharmacology, Faculty of Medicine and Pharmacy, University of Rabat, Rabat, Morocco

Professor F. Juma, Department of Clinical Pharmacology and Medicine, College of Health Science, University of Nairobi, Nairobi, Kenya

Dr G.P. Kilonzo, Senior Lecturer, Department of Psychiatry, Muhimbili Medical Centre, Dar-es-Salaam, United Republic of Tanzania

Professor L. Rago, Director-General, State Agency of Medicines, Tartu, Estonia (Chairman)

Representatives of other organizations*

*Unable to attend: Commonwealth Pharmaceutical Association (CPA); International Society of Infectious Disease (ISID); United Nations Industrial Development Organization (UNIDO).

International Federation of Pharmaceutical Manufacturers Associations (IFPMA)
Miss M. Cone, IFPMA, Geneva, Switzerland

International League of Dermatological Societies (ILDS)
Professor J.-H. Saurat, Dermatology Clinic, Cantonal Hospital, University of Geneva, Geneva, Switzerland

International Pharmaceutical Federation (FIP)
Professor F.W.H.M. Merkus, Center for Bio-Pharmaceutical Sciences, Gorlaeus Laboratories, Leiden, Netherlands

International Society of Chemotherapy (ISC)
Professor J.D. Williams, Department of Medical Microbiology, The London Hospital Medical College, London, England

International Union of Pharmacology (IUPHAR)
Professor J.-P. Giroud, Department of Pharmacology, Faculty of Medicine, René-Descartes University, Academy of Paris, Paris, France

United Nations Children’s Fund (UNICEF)
Ms H.B. Pedersen, Senior Technical Officer, Technical Services Centre, Supply Division, UNICEF Plads, Copenhagen, Denmark

World Self-Medication Industry (WSMI)
Dr J.A. Reinstein, Director-General, WSMI, London, England

Secretariat

Dr M.R. Couper, Medical Officer, Division of Drug Management and Policies, WHO, Geneva, Switzerland (Secretary)

Dr J. Idänpään-Heikkilä, Director, Division of Drug Management and Policies, WHO, Geneva, Switzerland

Professor W. Gardjito, Department of Surgery, Dr Soetomo Hospital, Surabaya, Indonesia (Temporary Adviser)

Dr T. Tsukada, Professor, Health Centre (Hoken Centre), Chuo University, Tokyo, Japan (Temporary Adviser)